Q1 FY2027 saw modest sales growth and strong fund business gains, with robust leading indicators supporting a positive outlook for the year. Record-high transactions under negotiation and new mandates position the company to achieve its Vision 300 targets, while regulatory changes and AI adoption are expected to provide competitive advantages.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.